Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Thomas Campbell

Concepts (644)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma, Kaposi
27
2026
83
6.940
 Why?
HIV Infections
116
2026
3148
6.380
 Why?
HIV-1
61
2023
897
4.260
 Why?
Anti-HIV Agents
47
2024
890
3.570
 Why?
Herpesvirus 8, Human
22
2024
67
3.190
 Why?
Antiretroviral Therapy, Highly Active
30
2023
278
2.420
 Why?
AIDS-Related Opportunistic Infections
14
2026
130
1.940
 Why?
Anti-Retroviral Agents
21
2024
250
1.680
 Why?
Zimbabwe
21
2026
76
1.620
 Why?
Acquired Immunodeficiency Syndrome
7
2023
235
1.330
 Why?
Viral Load
34
2023
528
1.310
 Why?
HIV Seropositivity
7
2021
119
1.280
 Why?
Biomarkers, Tumor
3
2026
1319
1.220
 Why?
International Cooperation
4
2018
197
1.120
 Why?
CD4 Lymphocyte Count
26
2023
277
0.990
 Why?
Inflammation
17
2026
2870
0.980
 Why?
Aging
9
2024
1938
0.940
 Why?
Education, Medical
3
2018
273
0.930
 Why?
alpha 1-Antichymotrypsin
1
2025
4
0.890
 Why?
Adult
103
2026
40489
0.870
 Why?
Gastrointestinal Microbiome
8
2026
771
0.850
 Why?
Middle Aged
79
2026
35971
0.840
 Why?
RNA, Viral
19
2014
689
0.820
 Why?
Humans
169
2026
144667
0.790
 Why?
Male
120
2026
72431
0.790
 Why?
Physical Fitness
2
2015
207
0.780
 Why?
Lung Neoplasms
3
2026
2660
0.770
 Why?
DNA, Viral
12
2013
357
0.750
 Why?
Female
113
2026
78304
0.730
 Why?
Tuberculosis
7
2023
291
0.710
 Why?
Drug Resistance, Viral
8
2015
123
0.690
 Why?
Herpesviridae Infections
7
2021
149
0.690
 Why?
Viremia
6
2011
159
0.680
 Why?
Antibodies, Viral
8
2023
672
0.660
 Why?
AIDS Dementia Complex
7
2015
52
0.640
 Why?
Antibiotics, Antineoplastic
4
2026
139
0.640
 Why?
Coinfection
6
2019
141
0.630
 Why?
CD4-Positive T-Lymphocytes
12
2023
1129
0.630
 Why?
Granulocyte Colony-Stimulating Factor
4
2004
89
0.600
 Why?
Nursing Staff, Hospital
1
2022
143
0.600
 Why?
Reverse Transcriptase Inhibitors
6
2015
87
0.600
 Why?
Lamivudine
6
2017
65
0.590
 Why?
Hematopoietic Stem Cell Mobilization
3
2004
27
0.580
 Why?
Lipopolysaccharide Receptors
2
2021
87
0.580
 Why?
Homosexuality, Male
6
2026
223
0.570
 Why?
Anemia
3
2023
189
0.560
 Why?
Vitamin D Deficiency
3
2017
187
0.560
 Why?
Breast Neoplasms
3
2026
2365
0.550
 Why?
HIV
8
2023
248
0.540
 Why?
Vitamin D
5
2018
400
0.530
 Why?
Mass Screening
1
2026
1348
0.500
 Why?
Plasma
4
2015
223
0.500
 Why?
Prospective Studies
23
2026
7994
0.490
 Why?
Micronutrients
4
2018
101
0.490
 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
2
2023
24
0.490
 Why?
Health Resources
5
2019
130
0.470
 Why?
Biomarkers
14
2026
4261
0.470
 Why?
Internationality
5
2019
154
0.460
 Why?
Motor Activity
3
2015
723
0.460
 Why?
RNA, Catalytic
4
1997
190
0.450
 Why?
Burnout, Professional
1
2022
483
0.430
 Why?
Benzoxazines
6
2017
31
0.430
 Why?
Developing Countries
10
2020
317
0.430
 Why?
Awareness
1
2015
109
0.430
 Why?
Cardiotoxicity
2
2026
34
0.430
 Why?
Zidovudine
7
2017
77
0.420
 Why?
Quality of Life
6
2019
3183
0.410
 Why?
HIV Integrase Inhibitors
1
2015
78
0.400
 Why?
C-Reactive Protein
5
2015
420
0.400
 Why?
Bronchoalveolar Lavage Fluid
6
2021
630
0.400
 Why?
Monocytes
2
2023
536
0.390
 Why?
Cytomegalovirus Infections
1
2015
205
0.390
 Why?
South America
8
2026
57
0.370
 Why?
Prevotella
2
2025
26
0.370
 Why?
Immune Reconstitution Inflammatory Syndrome
4
2020
20
0.370
 Why?
Doxorubicin
2
2026
398
0.360
 Why?
Disease Progression
11
2025
2847
0.360
 Why?
Aged
24
2025
25955
0.360
 Why?
Treatment Outcome
22
2023
11735
0.360
 Why?
Sarcopenia
1
2013
91
0.350
 Why?
Receptors, CCR5
5
2021
60
0.350
 Why?
Malnutrition
3
2018
86
0.340
 Why?
Case-Control Studies
9
2025
3603
0.340
 Why?
Pharmacogenetics
4
2026
172
0.320
 Why?
Prevalence
10
2026
2839
0.320
 Why?
Faculty, Medical
4
2018
301
0.320
 Why?
Osteoporosis
1
2013
236
0.320
 Why?
Africa
6
2020
118
0.310
 Why?
Antineoplastic Agents, Phytogenic
3
2020
176
0.310
 Why?
Neutropenia
1
2010
155
0.300
 Why?
Antiviral Agents
5
2017
765
0.300
 Why?
Accidental Falls
1
2012
221
0.300
 Why?
Virus Replication
6
2006
525
0.300
 Why?
Drug Therapy, Combination
10
2020
1044
0.300
 Why?
Sexual Behavior
4
2020
493
0.300
 Why?
Cross-Sectional Studies
10
2022
5870
0.290
 Why?
Tenofovir
6
2017
295
0.290
 Why?
Longitudinal Studies
10
2026
2942
0.290
 Why?
Thrombocytopenia
1
2010
202
0.280
 Why?
Randomized Controlled Trials as Topic
9
2025
1742
0.280
 Why?
Emergency Medical Services
1
2015
695
0.280
 Why?
Advance Care Planning
1
2012
243
0.280
 Why?
Viral Proteins
2
2008
353
0.270
 Why?
Genetic Variation
4
2008
985
0.270
 Why?
Professional Competence
2
2018
93
0.260
 Why?
Etoposide
4
2023
168
0.260
 Why?
Microbiota
4
2018
782
0.260
 Why?
Sex Characteristics
3
2023
776
0.260
 Why?
Atazanavir Sulfate
3
2016
42
0.250
 Why?
Health Services Accessibility
1
2015
1098
0.250
 Why?
Cohort Studies
20
2019
5957
0.250
 Why?
Cyclopropanes
6
2017
83
0.250
 Why?
Sexual and Gender Minorities
3
2021
254
0.250
 Why?
Incidence
9
2026
2892
0.250
 Why?
Survival Analysis
4
2015
1370
0.250
 Why?
Alkynes
6
2017
66
0.250
 Why?
Schools, Medical
2
2018
158
0.250
 Why?
Health Knowledge, Attitudes, Practice
1
2015
1406
0.250
 Why?
Drug Monitoring
1
2010
396
0.250
 Why?
Risk Factors
18
2025
10796
0.250
 Why?
Macrophages, Alveolar
2
2020
368
0.240
 Why?
Asia
5
2016
71
0.240
 Why?
CD8-Positive T-Lymphocytes
4
2021
915
0.230
 Why?
Feces
5
2025
513
0.230
 Why?
Sex Factors
4
2016
2104
0.230
 Why?
Treatment Failure
8
2018
365
0.230
 Why?
Genotype
7
2023
1847
0.230
 Why?
Drug Resistance, Multiple, Viral
1
2005
10
0.230
 Why?
Pregnancy Complications, Infectious
3
2018
431
0.220
 Why?
Needs Assessment
2
2018
401
0.220
 Why?
Young Adult
19
2023
14122
0.220
 Why?
Body Composition
2
2020
689
0.220
 Why?
Proportional Hazards Models
7
2018
1322
0.210
 Why?
Bronchoscopy
1
2026
227
0.210
 Why?
Immune System Diseases
1
2004
38
0.210
 Why?
Virus Latency
1
2004
90
0.210
 Why?
Salvage Therapy
1
2005
164
0.210
 Why?
Xenobiotics
1
2024
31
0.200
 Why?
Dideoxynucleosides
2
2014
24
0.200
 Why?
Lymph Nodes
3
2011
501
0.200
 Why?
Curriculum
4
2018
1063
0.200
 Why?
Bleomycin
2
2026
253
0.190
 Why?
Program Evaluation
2
2018
941
0.190
 Why?
Insulin-Like Growth Factor I
2
2017
317
0.190
 Why?
Heart Injuries
1
2023
42
0.190
 Why?
Interleukin-10
2
2023
310
0.190
 Why?
Urban Population
3
2026
493
0.180
 Why?
ADP-ribosyl Cyclase 1
2
2013
42
0.180
 Why?
Lung
8
2022
4089
0.180
 Why?
Nevirapine
2
2013
18
0.180
 Why?
Africa South of the Sahara
5
2026
53
0.180
 Why?
Neurocognitive Disorders
2
2019
33
0.180
 Why?
Plaque, Atherosclerotic
1
2023
60
0.180
 Why?
Myocarditis
1
2023
101
0.180
 Why?
Research Design
2
2025
1129
0.180
 Why?
Intestinal Mucosa
2
2021
675
0.180
 Why?
Lymphocytes
2
2023
379
0.180
 Why?
Speech
1
2022
78
0.170
 Why?
Surveys and Questionnaires
5
2022
6041
0.170
 Why?
Immunogenicity, Vaccine
1
2021
36
0.170
 Why?
United States
9
2023
16018
0.170
 Why?
Polymerase Chain Reaction
6
2021
1047
0.170
 Why?
Personnel Turnover
1
2022
41
0.170
 Why?
Emtricitabine
4
2017
205
0.170
 Why?
Adolescent
16
2023
22409
0.170
 Why?
Gastrointestinal Tract
2
2014
207
0.170
 Why?
Amyotrophic Lateral Sclerosis
1
2022
99
0.170
 Why?
B-Cell Maturation Antigen
1
2021
17
0.170
 Why?
Selenium
3
2018
49
0.170
 Why?
Multivariate Analysis
4
2015
1537
0.170
 Why?
Cognition
4
2017
1263
0.160
 Why?
Odds Ratio
2
2014
1076
0.160
 Why?
Thinking
1
2021
66
0.160
 Why?
Filgrastim
4
2004
13
0.160
 Why?
T-Lymphocytopenia, Idiopathic CD4-Positive
1
2020
6
0.160
 Why?
Leukapheresis
1
2000
27
0.150
 Why?
Intention
1
2022
187
0.150
 Why?
Pilot Projects
5
2014
1886
0.150
 Why?
Hematopoietic Stem Cells
2
2000
419
0.150
 Why?
Pyridazines
2
2012
57
0.150
 Why?
Workplace
1
2022
270
0.150
 Why?
Membrane Glycoproteins
2
2013
496
0.150
 Why?
Leadership
3
2018
400
0.150
 Why?
Vincristine
1
2020
140
0.150
 Why?
Job Satisfaction
1
2022
235
0.150
 Why?
Germ-Free Life
1
2019
33
0.150
 Why?
Weight Loss
3
2020
839
0.150
 Why?
Bacteria
3
2018
894
0.150
 Why?
Peripheral Nervous System Diseases
1
2020
133
0.150
 Why?
B-Lymphocytes
1
2004
875
0.150
 Why?
Epigenesis, Genetic
1
2024
669
0.150
 Why?
Hexosaminidases
1
2019
17
0.150
 Why?
DNA Methylation
1
2024
664
0.140
 Why?
Atherosclerosis
1
2023
409
0.140
 Why?
T-Lymphocytes, Regulatory
1
2021
394
0.140
 Why?
Exercise
2
2021
2183
0.140
 Why?
Clinical Trials as Topic
2
2016
1056
0.140
 Why?
Basal Ganglia
3
2014
57
0.140
 Why?
Brain
4
2019
2934
0.140
 Why?
Paclitaxel
3
2026
256
0.140
 Why?
Violence
1
2022
279
0.140
 Why?
Diet
1
2026
1270
0.140
 Why?
Cerebral Cortex
2
2013
470
0.140
 Why?
Organophosphonates
3
2013
97
0.140
 Why?
Genes, pol
3
2007
7
0.140
 Why?
Mutation
5
2016
4081
0.140
 Why?
Mouth
2
2015
88
0.140
 Why?
Suicide
2
2017
725
0.140
 Why?
AIDS Vaccines
1
2018
53
0.140
 Why?
Proteomics
1
2025
1183
0.130
 Why?
HIV Protease Inhibitors
2
2016
69
0.130
 Why?
Nucleic Acid Conformation
2
1997
728
0.130
 Why?
Capacity Building
1
2018
62
0.130
 Why?
Drug Combinations
2
2017
393
0.130
 Why?
Vitamin A Deficiency
1
2017
26
0.130
 Why?
Multiple Myeloma
1
2021
306
0.130
 Why?
Didanosine
2
2014
13
0.130
 Why?
Immunotherapy, Adoptive
1
2021
339
0.130
 Why?
Herpesvirus 2, Human
1
2017
27
0.130
 Why?
Early Detection of Cancer
1
2022
472
0.130
 Why?
Inflammation Mediators
2
2018
503
0.130
 Why?
Angiotensin Receptor Antagonists
1
2017
115
0.130
 Why?
Follow-Up Studies
7
2021
5414
0.120
 Why?
Financing, Organized
1
2017
36
0.120
 Why?
Dysbiosis
2
2021
187
0.120
 Why?
Anti-Inflammatory Agents
1
2020
477
0.120
 Why?
Hospitals
1
2022
729
0.120
 Why?
Recombinant Proteins
4
2004
1363
0.120
 Why?
Brain Injuries, Traumatic
1
2023
451
0.120
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2017
228
0.120
 Why?
Haiti
2
2016
14
0.120
 Why?
Genes, env
2
2007
5
0.120
 Why?
Coronary Artery Disease
1
2023
743
0.120
 Why?
Adenine
3
2013
337
0.120
 Why?
Immunoglobulin G
2
2023
886
0.120
 Why?
Lymphocyte Activation
3
2018
1124
0.120
 Why?
Magnetic Resonance Spectroscopy
3
2014
625
0.120
 Why?
Kaplan-Meier Estimate
3
2013
967
0.120
 Why?
Herpes Simplex
1
2017
98
0.120
 Why?
Nervous System Diseases
1
2019
285
0.120
 Why?
Tetrahymena thermophila
1
1996
69
0.120
 Why?
Mental Status and Dementia Tests
1
2016
26
0.120
 Why?
Ghana
1
2015
43
0.120
 Why?
Up-Regulation
1
2019
848
0.120
 Why?
Molecular Sequence Data
6
2013
2909
0.120
 Why?
TRPP Cation Channels
1
2016
74
0.110
 Why?
Cognitive Dysfunction
2
2019
464
0.110
 Why?
Muscle Strength
1
2018
330
0.110
 Why?
Ambulances
1
2015
53
0.110
 Why?
DNA, Protozoan
1
2015
32
0.110
 Why?
RNA, Protozoan
1
1995
60
0.110
 Why?
Hepatitis B, Chronic
1
2015
22
0.110
 Why?
Liver
1
2024
1889
0.110
 Why?
Plasmodium falciparum
1
2015
39
0.110
 Why?
Pregnancy Outcome
1
2018
479
0.110
 Why?
Rhodobacter sphaeroides
3
1983
7
0.110
 Why?
Chemokine CXCL10
1
2015
39
0.110
 Why?
Military Personnel
1
2023
733
0.110
 Why?
Cerebrospinal Fluid
1
2015
88
0.110
 Why?
Clinical Competence
2
2021
1237
0.110
 Why?
Retroviridae Infections
1
1995
47
0.110
 Why?
Research
1
2018
431
0.110
 Why?
Bone Morphogenetic Proteins
1
2015
142
0.110
 Why?
Malaria
1
2015
73
0.110
 Why?
Anthracyclines
1
2014
49
0.100
 Why?
Cytomegalovirus
1
2015
168
0.100
 Why?
Health Occupations
1
2014
36
0.100
 Why?
Orchitis
1
2014
5
0.100
 Why?
Penicillin G
1
2014
7
0.100
 Why?
Caribbean Region
2
2011
30
0.100
 Why?
Time Factors
3
2015
7140
0.100
 Why?
Pre-Exposure Prophylaxis
1
2017
247
0.100
 Why?
Health Care Surveys
1
2015
537
0.100
 Why?
Exercise Therapy
1
2018
475
0.100
 Why?
Syphilis
1
2014
32
0.100
 Why?
Stavudine
1
2013
6
0.100
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2017
438
0.100
 Why?
Phylogeny
3
2008
1024
0.100
 Why?
Seroepidemiologic Studies
2
2015
171
0.100
 Why?
Biota
1
2013
35
0.100
 Why?
Tropheryma
1
2013
6
0.100
 Why?
HIV Antigens
3
2015
17
0.100
 Why?
Whipple Disease
1
2013
7
0.100
 Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
32
0.100
 Why?
Pyrrolidinones
1
2013
29
0.100
 Why?
Aging, Premature
1
2013
16
0.100
 Why?
Metabolic Diseases
1
2014
114
0.100
 Why?
Genitalia, Male
1
2013
11
0.100
 Why?
Body Fat Distribution
1
2013
45
0.100
 Why?
Infectious Disease Transmission, Vertical
2
2012
193
0.100
 Why?
Peptide Fragments
3
2007
691
0.100
 Why?
Problem-Based Learning
1
2014
97
0.100
 Why?
Retinal Detachment
1
2014
73
0.100
 Why?
Education, Medical, Graduate
1
2018
562
0.090
 Why?
Genitalia, Female
1
2013
42
0.090
 Why?
Hospitals, University
1
2013
176
0.090
 Why?
Sequence Analysis, DNA
3
2013
828
0.090
 Why?
Fever
2
2021
313
0.090
 Why?
Genetic Therapy
1
1995
313
0.090
 Why?
Pregnancy
5
2018
7122
0.090
 Why?
Frail Elderly
1
2013
135
0.090
 Why?
Suicidal Ideation
2
2017
575
0.090
 Why?
Hepatitis B
1
2013
65
0.090
 Why?
Prostatitis
1
1992
17
0.090
 Why?
Aspergillosis
1
1992
24
0.090
 Why?
Muscles
1
2013
332
0.090
 Why?
Metagenome
1
2013
149
0.090
 Why?
Heart Failure
1
2025
2324
0.090
 Why?
RNA Stability
1
2013
119
0.090
 Why?
Weight Gain
1
2016
557
0.090
 Why?
Urinary Catheterization
1
1992
33
0.090
 Why?
Movement
1
2014
295
0.090
 Why?
Respiratory System
1
2013
151
0.090
 Why?
Withholding Treatment
1
2012
80
0.090
 Why?
Marijuana Smoking
1
2015
249
0.090
 Why?
Universities
1
2014
452
0.090
 Why?
Body Weight
1
2016
968
0.090
 Why?
Unsafe Sex
1
2012
61
0.090
 Why?
Confidence Intervals
1
2012
331
0.090
 Why?
HIV Core Protein p24
3
2006
32
0.090
 Why?
Catheters, Indwelling
1
1992
97
0.090
 Why?
Tumor Necrosis Factor-alpha
3
2022
1207
0.090
 Why?
Echocardiography
2
2026
644
0.090
 Why?
Exanthema
1
2012
84
0.090
 Why?
Lipopolysaccharides
1
2015
854
0.080
 Why?
Pulmonary Disease, Chronic Obstructive
1
2019
919
0.080
 Why?
Education, Medical, Undergraduate
1
2014
205
0.080
 Why?
Neuropsychological Tests
4
2019
1134
0.080
 Why?
CD4 Antigens
1
2011
137
0.080
 Why?
Smoking
2
2020
1467
0.080
 Why?
Polyneuropathies
1
2011
57
0.080
 Why?
Corpus Callosum
1
2011
72
0.080
 Why?
Americas
1
2010
26
0.080
 Why?
Mycobacterium tuberculosis
2
2012
337
0.080
 Why?
Piperazines
1
1993
378
0.080
 Why?
T-Lymphocyte Subsets
2
2011
412
0.080
 Why?
Veterans
1
2023
1614
0.080
 Why?
HLA-DR Antigens
1
2011
220
0.080
 Why?
Body Mass Index
3
2014
2419
0.080
 Why?
Kidney Diseases
1
2014
427
0.080
 Why?
Bone and Bones
1
2013
317
0.080
 Why?
RNA, Ribosomal, 16S
3
2019
564
0.080
 Why?
Patient Compliance
1
2014
587
0.080
 Why?
Fluorescent Antibody Technique
3
2015
364
0.080
 Why?
Antigens, Viral
2
2021
182
0.080
 Why?
Interleukin-6
3
2022
770
0.080
 Why?
Endothelial Cells
2
2024
864
0.080
 Why?
HIV Reverse Transcriptase
2
2004
31
0.080
 Why?
Specimen Handling
1
2011
187
0.080
 Why?
HIV Fusion Inhibitors
2
2007
3
0.080
 Why?
HIV Envelope Protein gp41
2
2007
11
0.080
 Why?
Tuberculosis, Pulmonary
2
2013
131
0.070
 Why?
Bone Density
1
2013
484
0.070
 Why?
Health Personnel
1
2016
746
0.070
 Why?
Emigrants and Immigrants
1
2012
158
0.070
 Why?
Smokers
2
2020
137
0.070
 Why?
Metabolic Syndrome
1
2012
354
0.070
 Why?
RNA
1
1995
926
0.070
 Why?
Neuroimaging
1
2011
293
0.070
 Why?
Epitopes, T-Lymphocyte
2
2006
175
0.070
 Why?
Lung Diseases
1
2015
781
0.070
 Why?
Uganda
1
2008
92
0.070
 Why?
South Africa
3
2016
265
0.070
 Why?
Leukocytes, Mononuclear
2
2021
572
0.070
 Why?
Cytokines
3
2021
2045
0.070
 Why?
Socioeconomic Factors
1
2012
1322
0.070
 Why?
Base Composition
2
1997
84
0.060
 Why?
Sweating
1
2007
42
0.060
 Why?
Blood Vessels
1
2008
167
0.060
 Why?
Amino Acid Sequence
3
2006
2136
0.060
 Why?
Organizational Culture
2
2018
160
0.060
 Why?
Vitamin A
2
2018
59
0.060
 Why?
Healthy Volunteers
2
2018
215
0.060
 Why?
Colorado
3
2012
4558
0.060
 Why?
Purine Nucleosides
1
2006
4
0.060
 Why?
Dioxolanes
1
2006
6
0.060
 Why?
Gender Identity
1
2007
126
0.060
 Why?
Peru
2
2016
62
0.060
 Why?
Gene Products, gag
1
2006
38
0.060
 Why?
Program Development
2
2018
368
0.060
 Why?
Substrate Specificity
2
1997
392
0.060
 Why?
DNA, Bacterial
3
2019
347
0.060
 Why?
Phospholipids
3
1983
214
0.060
 Why?
Biopsy
2
2020
1079
0.060
 Why?
Retrospective Studies
4
2023
17149
0.060
 Why?
Logistic Models
3
2015
2114
0.060
 Why?
Selection Bias
1
2005
38
0.060
 Why?
Disease Reservoirs
1
2004
25
0.050
 Why?
Hypoalbuminemia
1
2024
27
0.050
 Why?
Dizziness
2
2018
101
0.050
 Why?
HIV Protease
1
2004
4
0.050
 Why?
Hepatocyte Nuclear Factor 4
1
2024
15
0.050
 Why?
HIV Envelope Protein gp120
1
2004
55
0.050
 Why?
Linear Models
3
2011
845
0.050
 Why?
Comorbidity
1
2009
1652
0.050
 Why?
Double-Blind Method
3
2018
2033
0.050
 Why?
Base Sequence
3
1996
2177
0.050
 Why?
WT1 Proteins
1
2024
12
0.050
 Why?
CASP8 and FADD-Like Apoptosis Regulating Protein
1
2024
19
0.050
 Why?
Syndrome
1
2004
379
0.050
 Why?
Castleman Disease
1
2003
16
0.050
 Why?
Matrix Metalloproteinase 2
1
2023
55
0.050
 Why?
Animals
7
2024
37948
0.050
 Why?
Aspartic Acid
2
2014
87
0.050
 Why?
Glucuronosyltransferase
1
2023
18
0.050
 Why?
Endemic Diseases
1
2003
33
0.050
 Why?
Receptors, Tumor Necrosis Factor
1
2023
161
0.050
 Why?
Hospitalization
2
2025
2446
0.050
 Why?
Anti-Bacterial Agents
1
2014
1928
0.050
 Why?
Reference Values
2
2016
794
0.050
 Why?
Polymorphism, Single Nucleotide
2
2023
2137
0.050
 Why?
United Kingdom
2
2014
337
0.050
 Why?
Speech Intelligibility
1
2022
4
0.050
 Why?
Binding Sites
2
1996
1307
0.050
 Why?
Speech Production Measurement
1
2022
12
0.050
 Why?
Choline
2
2014
136
0.050
 Why?
Lip
1
2022
22
0.050
 Why?
Interferon-gamma
1
2006
781
0.050
 Why?
Jaw
1
2022
27
0.050
 Why?
Protein Isoforms
1
2024
396
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
973
0.040
 Why?
Tongue
1
2022
77
0.040
 Why?
Lopinavir
2
2013
30
0.040
 Why?
Chemoradiotherapy
1
2023
239
0.040
 Why?
Risk Assessment
2
2025
3729
0.040
 Why?
Intention to Treat Analysis
1
2021
79
0.040
 Why?
Ritonavir
2
2013
75
0.040
 Why?
Magnetic Resonance Imaging
2
2011
3888
0.040
 Why?
Ligands
1
2023
662
0.040
 Why?
Deoxycytidine
2
2014
222
0.040
 Why?
Patient Acuity
1
2021
47
0.040
 Why?
Immunization, Secondary
1
2021
92
0.040
 Why?
Frontal Lobe
2
2014
159
0.040
 Why?
Receptors, Tumor Necrosis Factor, Type II
1
2021
41
0.040
 Why?
Vidarabine
1
2021
32
0.040
 Why?
Cardiovascular Diseases
1
2013
2172
0.040
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2021
80
0.040
 Why?
Rural Population
1
2026
657
0.040
 Why?
Hemoglobins
1
2023
381
0.040
 Why?
Regression Analysis
2
2014
998
0.040
 Why?
T-Lymphocytes, Cytotoxic
1
2001
177
0.040
 Why?
Reproducibility of Results
3
2008
3414
0.040
 Why?
Vascular Endothelial Growth Factor A
1
2023
550
0.040
 Why?
Antibodies, Neutralizing
1
2023
341
0.040
 Why?
Single-Blind Method
1
2021
319
0.040
 Why?
Prognosis
2
2026
4312
0.040
 Why?
Cell Line
3
2001
2821
0.040
 Why?
Cyclophosphamide
1
2021
265
0.040
 Why?
Cells, Cultured
4
2008
4110
0.040
 Why?
Integrin alpha Chains
1
2020
22
0.040
 Why?
Sensitivity and Specificity
2
2007
1995
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
2
2015
835
0.040
 Why?
Cough
1
2021
123
0.040
 Why?
Antigens, CD34
1
2000
88
0.040
 Why?
Fatty Acids
1
1983
454
0.040
 Why?
Genome, Bacterial
1
2021
158
0.040
 Why?
Virion
1
2000
111
0.040
 Why?
Brazil
2
2016
182
0.040
 Why?
Tumor Microenvironment
1
2024
729
0.040
 Why?
Immunophenotyping
1
2020
318
0.040
 Why?
Immunologic Memory
1
2001
366
0.040
 Why?
Biomechanical Phenomena
1
2022
852
0.040
 Why?
Nitriles
2
2012
205
0.040
 Why?
Diffusion Tensor Imaging
1
2019
75
0.040
 Why?
Teacher Training
1
2018
10
0.030
 Why?
Atrophy
1
2019
199
0.030
 Why?
Aspartate Aminotransferases
1
2018
85
0.030
 Why?
Genes, vpr
1
1997
1
0.030
 Why?
Motor Skills
1
2019
104
0.030
 Why?
Genes, vif
1
1997
3
0.030
 Why?
Trace Elements
1
2018
52
0.030
 Why?
Colony Count, Microbial
1
2018
123
0.030
 Why?
Back Pain
1
2018
52
0.030
 Why?
DNA Primers
2
1996
507
0.030
 Why?
Cytochrome P-450 CYP2B6
1
2017
9
0.030
 Why?
Stillbirth
1
2018
79
0.030
 Why?
Cytochrome P-450 CYP2A6
1
2017
8
0.030
 Why?
Macaca mulatta
1
2018
186
0.030
 Why?
Adenoviridae
1
2018
199
0.030
 Why?
Principal Component Analysis
1
2018
195
0.030
 Why?
Immunity, Humoral
1
2018
120
0.030
 Why?
Genome-Wide Association Study
1
2024
1374
0.030
 Why?
In Vitro Techniques
1
2019
1046
0.030
 Why?
Colon
1
2020
307
0.030
 Why?
Diarrhea
1
2018
192
0.030
 Why?
Abdominal Pain
1
2018
147
0.030
 Why?
Toll-Like Receptors
1
2018
193
0.030
 Why?
Genetic Vectors
1
2018
334
0.030
 Why?
Seroconversion
1
2017
48
0.030
 Why?
Antigens, CD
1
2020
552
0.030
 Why?
Oligoribonucleotides
1
1996
52
0.030
 Why?
Benzoxazoles
1
1996
19
0.030
 Why?
Immunity, Cellular
1
2018
272
0.030
 Why?
Ruthenium Red
1
2016
7
0.030
 Why?
Amiloride
1
2016
25
0.030
 Why?
Thailand
1
2016
18
0.030
 Why?
Gene Frequency
1
2017
481
0.030
 Why?
Malawi
1
2016
57
0.030
 Why?
Immunosuppressive Agents
1
2021
834
0.030
 Why?
Pyrimidines
2
2012
519
0.030
 Why?
Life Style
1
2018
481
0.030
 Why?
Fatigue
1
2018
363
0.030
 Why?
Administration, Oral
1
2018
851
0.030
 Why?
Patient Selection
1
2000
727
0.030
 Why?
Age Factors
2
2016
3329
0.030
 Why?
Nutritional Status
1
2018
351
0.030
 Why?
India
1
2016
220
0.030
 Why?
Catalysis
1
1996
319
0.030
 Why?
Parasitemia
1
2015
15
0.030
 Why?
Human Activities
1
2015
21
0.030
 Why?
Verbal Learning
1
2016
73
0.030
 Why?
pol Gene Products, Human Immunodeficiency Virus
1
2015
1
0.030
 Why?
Hepatitis B virus
1
2015
33
0.030
 Why?
Gene Knockdown Techniques
1
2016
334
0.030
 Why?
Point Mutation
1
2016
242
0.030
 Why?
Tetrahymena
1
1995
158
0.030
 Why?
Placebos
1
2015
193
0.030
 Why?
Carotenoids
1
2015
48
0.030
 Why?
Genotyping Techniques
1
2015
70
0.030
 Why?
RNA Splicing
1
1996
286
0.030
 Why?
Chronic Disease
2
2014
1810
0.030
 Why?
Nuclear Proteins
1
1999
741
0.030
 Why?
Pyridones
1
1996
201
0.030
 Why?
World Health Organization
1
2014
104
0.030
 Why?
Vitamin E
1
2015
123
0.030
 Why?
Vaccination
1
2023
1419
0.030
 Why?
Schools, Health Occupations
1
2014
8
0.030
 Why?
Genetic Markers
1
2015
332
0.030
 Why?
Retreatment
1
2014
77
0.030
 Why?
Premature Birth
1
2018
376
0.030
 Why?
Developed Countries
1
2014
38
0.030
 Why?
Mice
2
2024
18261
0.030
 Why?
Ophthalmoscopy
1
2014
38
0.030
 Why?
Fellowships and Scholarships
1
2018
355
0.030
 Why?
Dose-Response Relationship, Drug
1
2018
2019
0.030
 Why?
Creatine
1
2014
63
0.030
 Why?
Diffusion of Innovation
1
2014
95
0.030
 Why?
Psychology
1
2014
88
0.030
 Why?
Group Processes
1
2014
63
0.020
 Why?
Educational Status
1
2016
463
0.020
 Why?
Protons
1
2014
97
0.020
 Why?
Raltegravir Potassium
1
2013
18
0.020
 Why?
DNA, Ribosomal
1
2013
97
0.020
 Why?
Bronchoalveolar Lavage
1
2013
88
0.020
 Why?
Inositol
1
2013
25
0.020
 Why?
Skin
1
2018
762
0.020
 Why?
Gray Matter
1
2014
92
0.020
 Why?
Hepatitis B Surface Antigens
1
2013
17
0.020
 Why?
Polymorphism, Genetic
1
2016
613
0.020
 Why?
Phenotype
2
2014
3147
0.020
 Why?
Kinetics
1
1996
1602
0.020
 Why?
Mice, Inbred C57BL
1
2024
5967
0.020
 Why?
Oligopeptides
1
2014
266
0.020
 Why?
Programmed Cell Death 1 Receptor
1
2015
264
0.020
 Why?
Polycystic Kidney, Autosomal Dominant
1
2016
235
0.020
 Why?
Medication Adherence
1
2017
540
0.020
 Why?
Global Health
1
2015
401
0.020
 Why?
Risk
1
2015
911
0.020
 Why?
Gene Expression Regulation
2
2014
2591
0.020
 Why?
Adaptor Proteins, Signal Transducing
1
2015
426
0.020
 Why?
White Matter
1
2014
153
0.020
 Why?
Neurologic Examination
1
2012
132
0.020
 Why?
Cause of Death
1
2014
464
0.020
 Why?
Microbial Sensitivity Tests
1
1993
373
0.020
 Why?
Hypertension, Pulmonary
1
2003
1948
0.020
 Why?
Receptors, HIV
1
2011
23
0.020
 Why?
Kidney Failure, Chronic
1
2017
597
0.020
 Why?
Blood Coagulation
1
2013
268
0.020
 Why?
Psychological Tests
1
2012
132
0.020
 Why?
Zebrafish
1
2016
532
0.020
 Why?
Data Collection
1
2014
635
0.020
 Why?
Glutamic Acid
1
2013
254
0.020
 Why?
Flow Cytometry
1
2015
1154
0.020
 Why?
Cooperative Behavior
1
2014
464
0.020
 Why?
Headache
1
2012
151
0.020
 Why?
Mood Disorders
1
2012
140
0.020
 Why?
Models, Theoretical
1
2014
578
0.020
 Why?
Visual Acuity
1
2014
491
0.020
 Why?
Biological Specimen Banks
1
2011
105
0.020
 Why?
Mozambique
1
2010
7
0.020
 Why?
Suicide, Attempted
1
2014
421
0.020
 Why?
Pyridines
1
2014
603
0.020
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1961
0.020
 Why?
Calcium
1
2016
1182
0.020
 Why?
Social Support
1
2014
650
0.020
 Why?
North America
1
2011
312
0.020
 Why?
Pyrimidinones
1
2010
125
0.020
 Why?
Gene Expression
1
1995
1476
0.020
 Why?
Statistics, Nonparametric
1
2010
427
0.020
 Why?
T-Lymphocytes
1
2018
1984
0.020
 Why?
Feasibility Studies
1
2014
1103
0.020
 Why?
Antitubercular Agents
1
2011
216
0.020
 Why?
Neuroglia
1
2010
173
0.020
 Why?
Thalamus
1
2010
127
0.020
 Why?
Students, Medical
1
2014
374
0.020
 Why?
Multicenter Studies as Topic
1
2010
408
0.020
 Why?
Organ Size
1
2010
461
0.020
 Why?
Caspase 7
1
2008
22
0.020
 Why?
Predictive Value of Tests
1
2014
2117
0.020
 Why?
In Situ Nick-End Labeling
1
2008
120
0.020
 Why?
Mental Health
1
2015
792
0.020
 Why?
Bone Morphogenetic Protein 4
1
2008
43
0.020
 Why?
Culture Media, Conditioned
1
2008
111
0.020
 Why?
Sleep Wake Disorders
1
2012
308
0.020
 Why?
Caspase 3
1
2008
234
0.020
 Why?
T-Cell Antigen Receptor Specificity
1
2006
45
0.020
 Why?
Endothelium, Vascular
1
2013
949
0.020
 Why?
Fluorides
1
2006
49
0.020
 Why?
Polyurethanes
1
2006
38
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2008
751
0.010
 Why?
gag Gene Products, Human Immunodeficiency Virus
1
2006
10
0.010
 Why?
Methacrylates
1
2006
119
0.010
 Why?
Computer Simulation
1
2010
1021
0.010
 Why?
Sequence Alignment
1
2006
371
0.010
 Why?
Alleles
1
2007
886
0.010
 Why?
Carrier Proteins
1
2008
733
0.010
 Why?
Guanosine Tetraphosphate
1
1983
5
0.010
 Why?
Cerulenin
1
1983
1
0.010
 Why?
Linoleic Acids
1
1983
6
0.010
 Why?
Linolenic Acids
1
1983
2
0.010
 Why?
Light
2
1983
405
0.010
 Why?
Oleic Acids
1
1983
12
0.010
 Why?
Severity of Illness Index
1
2011
2922
0.010
 Why?
Linoleic Acid
1
1983
44
0.010
 Why?
Oleic Acid
1
1983
42
0.010
 Why?
Nucleotides
1
1983
130
0.010
 Why?
Fatty Acids, Unsaturated
1
1983
96
0.010
 Why?
Membrane Lipids
1
1983
82
0.010
 Why?
Models, Biological
1
2010
1811
0.010
 Why?
Cytotoxicity Tests, Immunologic
1
2001
37
0.010
 Why?
Bacteriological Techniques
1
1981
68
0.010
 Why?
Aged, 80 and over
1
2013
8284
0.010
 Why?
Apoptosis
1
2008
2397
0.010
 Why?
Cardiac Catheterization
1
2003
557
0.010
 Why?
Immunohistochemistry
1
2003
1705
0.010
 Why?
HIV Seronegativity
1
1998
29
0.010
 Why?
Infant
1
2012
10023
0.010
 Why?
Substance Abuse, Intravenous
1
1998
127
0.010
 Why?
Antipyrine
1
1996
12
0.010
 Why?
Drug Resistance, Microbial
1
1996
71
0.010
 Why?
Drug Interactions
1
1996
401
0.010
 Why?
Cross-Over Studies
1
1996
605
0.010
 Why?
Intracellular Membranes
1
1981
76
0.000
 Why?
Cell Division
1
1981
753
0.000
 Why?
Campbell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (644) concept(s)
_
Co-Authors Expand Description
See all (63) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)